Use of Specific T Lymphocytes in Treating Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients: A Systematic Review

Use of Specific T Lymphocytes in Treating Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients: A Systematic Review

Cytomegalovirus (CMV) poses a significant threat to post-hematopoietic cell transplantation (HCT). Control strategies include letermovir prophylaxis or ganciclovir pre-emptive therapy (PET). Without prophylaxis, 65–90% of seropositive recipients develop a clinically significant CMV infection. Due to...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Tayná F. G. S. Bandeira, Luciana C. Marti, Edna T. Rother, Lucas Reis Correia, Clarisse M. Machado
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: MDPI AG 2024-10-01
Seri Bilgileri:Pharmaceutics
Konular:
specific T lymphocytes
hematopoietic cell transplant
cytomegalovirus infection
Online Erişim:https://www.mdpi.com/1999-4923/16/10/1321

Internet

https://www.mdpi.com/1999-4923/16/10/1321

Benzer Materyaller